Dr. Prashant Vilas Bhangui (Surgical Gastroenterologist)

About Dr. Prashant Vilas Bhangui

• Dr. Prashant Vilas Bhangui is a surgical gastroenterologist and liver transplant specialist with 16+ years of experience.
• He completed a Masters Programme in HPB Surgery and Liver Transplantation at the Henri Bismuth Hepatobiliary Institute, France followed by a Fellowship from Centre Hepatobiliare Hospital Paul Brouse, Paris.
• He holds a European Inter-University Diploma in Hepato-Biliary-Pancreatic Cancers from Universite Paris XI, France and was awarded the Merck KGaA Germany International Educational Grant for clinical research.
• His areas of special interest include hepatocellular carcinoma colorectal liver metastases and living donor liver transplantation.
• He has several publications in key peer-reviewed International journals.
• He is also on the Reviewer Panel for Journal of Hepatology Liver Transplantation World Journal of Surgery.
• He is a member of International Liver Transplantation Society (ILTS), European Society for Organ Transplantation (ESOT), European Liver Transplant Association(ELITA), American Association for the Study of Liver Diseases (AASLD), The Transplantation Society (TTS), International Living Donor Liver Transplant (ILDLT), International Association of Surgeons, Gastroenterologists, Oncologists (IASGO) and Indian Society for Organ Transplantation (ISOT).
• He has won “Vanguard Award 2016” for Best Published Clinical Research Paper, Dr. K.N. Udupa Memorial Oration 2016” for Outstanding Research and contributing to the development of Organ Transplantation in India, Best paper award and more.

Special Interest

Hepatobiliary Surgery, Hepatocellular Carcinoma management, Management of colorectal liver metastases

Education

• Diploma, 2009, Universite Paris XI, France

• MS, 2004, Goa Medical College, Goa

• MBBS, 2000, Goa Medical College, Goa

Awards

1. Vanguard Award 2016” for Best Published Clinical Research Paper 2. Dr. K.N. Udupa Memorial Oration 2016” for Outstanding Research and contributing to the development of Organ Transplantation in India 3. Best Paper Award, Seoul, South Korea, 2015 4. Award papers at the 20th Annual International Congress of ILTS, London, 2014 5. Award papers at the XXII Annual Conference of the Indian Association of Surgical Gastroenterology, Bengaluru, India, 2012 6. Award paper at the 19th Annual International Congress of the ILTS, Sydney, 2013; 18th Annual International Congress ILTS, San Francisco, 2012

Paper Published

• Ann Surg. 2016;264:155-63: Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?, 2016
• HPB (Oxford) 2017;19:638 648: The impact of expanded indications on short term outcomes for resection of malignant tumours of the liver over a 30 year period.,
• Clin Transplant. 2017:31:5.: (D+10) MELD as a novel predictor of patient and graft survival after adult to adult living donor liver transplantation,
• Ann Surg 2015;261:e109-10. :   “Resection or Transplantation for Early Hepatocellular Carcinoma in a Cirrhotic Liver: Does Size Define the Best Oncological Strategy?”, 2015
• HPB (Oxford). 2014;Aug;16(8):723-38: Portal Vein Arterialization: a salvage procedure for a totally de-arterialized liver. The Paul Brousse Hospital Experience, 2014
• Indian J Gastroenterol. 2015;34:305-9.: Genotype 3 and higher low-density lipoprotein levels are predictors of good response to treatment of recurrent hepatitis C following living donor liver transplantation
• Indian J Gastroenterol. 2014; 33:72-6: The use of ABO-incompatible grafts in living donor liver transplantation – first report from India
• Ann Surg. 2012;256:883-91: Resection or Transplantation for Early Hepatocellular Carcinoma in a Cirrhotic Liver: Does Size Define the Best Oncological Strategy?
• European Oncology 2010;6:37-40: Liver Resection of Colorectal Metastases in Elderly Patients,
• Ann Surg. 2010;252:774-87: Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?
• Cancer News (Rajiv Gandhi Cancer Institute and Research Centre) 2011;5:6-9. : Liver Transplantation for Hepatocellular Carcinoma.